DNASanger

DNA sequencing stands as the foundational pillar of modern molecular biology and genetics. Since its inception in the 1970s, the ability to decode genomic information has undergone a transformative evolution—shifting from manual, labor-intensive processes to automated, ultra-high-throughput platforms. In the landscape of genetic research, selecting the appropriate sequencing technology is a critical determinant of experimental success. This article explores the two most pivotal technologies in the field: Sanger sequencing and Next-Generation Sequencing (NGS), evaluating their underlying principles, performance metrics, and optimal use cases.

Within the grand scheme of genetic research, DNA sequencing serves as the essential bridge connecting genotype to phenotype. Whether investigating the molecular basis of classical Mendelian disorders, dissecting complex quantitative traits across populations, or pinpointing pathogenic mutations in human disease, precise DNA determination remains indispensable.

From a macroscopic perspective, the evolution of sequencing technology can be divided into three distinct phases:

• First-Generation Sequencing: Represented by the Sanger dideoxy chain-termination method, characterized by exceptional accuracy but limited throughput and high costs.
• Second-Generation Sequencing (NGS): Centered around sequencing by synthesis (SBS), enabling massive parallel processing of data and drastically reducing per-base costs.
• Third/Fourth-Generation Sequencing: Single-molecule real-time and nanopore sequencing, distinguished by ultra-long read lengths and the elimination of PCR amplification biases.

This discussion will focus primarily on the first-generation Sanger method, which laid the groundwork for modern genomics, and second-generation NGS, which dominates contemporary large-scale sequencing endeavors.
Developed by Frederick Sanger in 1977, the Sanger method remains a cornerstone of DNA sequencing. Its core mechanism relies on the dideoxy chain termination method.

Core Principles

Sanger sequencing leverages DNA polymerase to synthesize a complementary strand along a single-stranded template. The reaction mixture contains the four standard deoxynucleotides (dNTPs) alongside a small proportion of fluorescently labeled dideoxynucleotides (ddNTPs). Because a ddNTP lacks a 3'-hydroxyl group, it cannot form the phosphodiester bond required for chain elongation. Once a ddNTP is randomly incorporated into the growing strand, the polymerization reaction terminates immediately.

The resulting mixture of truncated fragments is then separated by capillary electrophoresis based on their molecular length. A laser scanner detects the fluorescent signal at the end of each fragment, converting the emission peaks into a nucleotide sequence.

Key Characteristics

• Long Read Length: A single reaction can reliably yield effective reads up to 800-1000 base pairs (bp).
• Exceptional Accuracy: With precision routinely exceeding 99.99%, Sanger is universally acknowledged as the "gold standard" for sequence validation.
• Throughput and Cost Limitations: As a low-throughput technology, it is unsuitable for large-scale initiatives like whole-genome sequencing, and the per-sample cost remains relatively high.

Next-Generation Sequencing (NGS): High Throughput and Parallelization

To meet the escalating demand for massive genomic datasets, Next-Generation Sequencing (NGS) emerged. The defining innovation of NGS is massively parallel sequencing, which allows millions to billions of individual DNA molecules to be sequenced simultaneously.

Mainstream Platforms and Workflows

The dominant NGS platforms today are Illumina's sequencing systems (such as NovaSeq and HiSeq). A standard NGS workflow encompasses the following critical steps:

1. Library Preparation: Genomic DNA is fragmented into short pieces, and specific adapter sequences are ligated to both ends of the fragments.
2. Cluster Generation (Bridge PCR): The adapter-ligated fragments bind to complementary oligonucleotide primers fixed on the surface of a flow cell. Through bridge amplification, localized clonal clusters of identical DNA sequences are generated.
3. Sequencing by Synthesis (SBS): Fluorescently labeled reversible terminator dNTPs are introduced. During each cycle, DNA polymerase incorporates a single nucleotide. Unincorporated bases are washed away, the flow cell is imaged to record the fluorescence, and then the fluorescent dye and termination block are cleaved, allowing the next synthesis cycle to proceed.

Key Characteristics

• Ultra-High Throughput: A single instrument run can generate gigabases (Gb) to terabases (Tb) of data, dramatically accelerating sequencing timelines.
• Exponentially Lower Cost: The per-base cost of sequencing has plummeted, making large-scale projects economically feasible.
• Shorter Read Lengths: Standard Illumina reads typically range from 100 bp to 300 bp. This short-read constraint presents distinct challenges for de novo assembly of complex or highly repetitive genomes.

Technology Comparison and Experimental Design Selection

When designing genetic experiments, researchers must carefully weigh the trade-offs between Sanger sequencing and NGS based on their specific objectives, sample volumes, and financial constraints:

In practical applications, these two technologies are highly complementary. For instance, in the study of human genetic diseases, researchers typically employ NGS via targeted gene panels or whole-exome sequencing to conduct high-throughput screening for candidate pathogenic variants. Once a suspicious mutation is identified, specific primers are designed, and Sanger sequencing is utilized to independently verify the mutation. This synergistic approach ensures the rigorous accuracy required for both clinical diagnostics and foundational scientific conclusions.